Health In Tech Registers 29.5M Shares for Yorkville SEPA — $7M Convertible Note Already Funded
HIT sits 16% above its 52-week low of $0.85.
Summary
Health In Tech registered 29.5 million shares for resale by Yorkville under a new Standby Equity Purchase Agreement, with a $7 million convertible note already funded and up to $20 million in additional equity available. Full issuance would dilute existing holders by approximately 35.5%.
Key Events · Financing and Capital Events · HIT
-
SEPA with Yorkville Registered
An S-3 was filed to register 29,532,889 shares for resale by Yorkville under a Standby Equity Purchase Agreement dated August 12, 2026, consisting of 9,532,889 Conversion Shares and 20,000,000 Advance Shares.
-
$7M Convertible Note Already Funded
Yorkville disbursed $6.65 million net on August 18, 2026 for a $7 million First Convertible Note at a 5% discount, with a fixed conversion price of $1.5735 per share and 8.75% annual interest.
-
Potential 35.5% Dilution
If all 29,532,889 shares were issued, they would represent approximately 35.5% of the 53,702,649 shares outstanding as of September 2, 2026, and 58.9% of the non-affiliate float.
-
Exchange Cap Requires Stockholder Vote
Nasdaq rules cap issuance to Yorkville at 13,100,378 shares (19.99% of outstanding) unless stockholders approve exceeding the cap at the November 5, 2026 annual meeting.
Analysis · HIT · Finance
A new Standby Equity Purchase Agreement with Yorkville could dilute existing shareholders by up to 35.5% if fully drawn. The company already received $6.65 million in net proceeds from a $7 million convertible note on August 18, 2026, with two more tranches potentially adding another $7.75 million. The convertible notes carry an 8.75% interest rate and a fixed conversion price of $1.5735 — well above the current $0.98 share price — meaning Yorkville has significant incentive to convert only if the stock recovers, but the Advance Shares can be sold at 97% of the lowest VWAP, creating downward pressure. Stockholder approval at the November 5, 2026 annual meeting is needed to issue beyond the 13.1 million share Exchange Cap, making that vote a critical governance event. Against a backdrop of Q2 net losses and negative operating cash flow, this financing provides runway but at the cost of substantial potential dilution.
How filings like this one have moved
In the 30 days to Sep 10, 2026, 35.8% of the 1864 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, HIT was trading at $0.98 on NASDAQ in the Finance sector, with a market capitalization of approximately $64.5M. The 52-week trading range was $0.85 to $4.02. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.